Genialis, a leader in applied data science for the development of precision medicines, today announced together with the Bioinformatics Laboratory at the University of Ljubljana that the organisations have entered into a Sponsored Research Agreement to develop new algorithms and methods to better assign patients to therapeutic options based on disease subtypes, deepening Genialis’ investment and expertise in machine-learning-based drug discovery.


Read the press release in its entirety here.

Share this story, choose your platform!